Log in

3320 China Resources Pharmaceutical Group Ltd. HKEX · Hong Kong

China Resources Pharmaceutical Group (3320) news

Latest China Resources Pharmaceutical Group news

  1. Debt Financing

    China Resources Pharmaceutical unit issues RMB900 million corporate bonds

    A wholly owned subsidiary completed the second tranche of its 2026 corporate bonds in the PRC, RMB900 million at 1.48% per annum over three years.

  2. Debt Financing

    KPC gets registration for RMB1 billion medium term notes

    A non-wholly owned subsidiary of China Resources Pharmaceutical received a two-year registration for up to RMB1 billion of medium term notes.

  3. Debt Financing

    China Resources Pharmaceutical issues RMB1 billion second tranche of notes

    A wholly owned subsidiary completed the second 2026 tranche of medium term notes, RMB1 billion at 1.52% per annum over three years.

  4. Debt Financing

    China Resources Pharmaceutical issues RMB1 billion medium term notes

    A wholly owned subsidiary completed the first tranche of its 2026 medium term notes on 21 July 2026, at 1.53% per annum over 3 years.

  5. Debt Financing

    China Resources Pharmaceutical unit issues RMB2 billion corporate bonds

    A non-wholly owned subsidiary completed the third tranche of its 2026 corporate bonds, RMB2 billion at 1.59% per annum over three years.

  6. Debt Financing

    China Resources Pharmaceutical plans RMB5 billion medium term notes

    A wholly owned subsidiary received registration for up to RMB5 billion of medium term notes, valid for two years, with no issue announced yet.

Questions about China Resources Pharmaceutical Group

What is the ticker symbol of China Resources Pharmaceutical Group?

China Resources Pharmaceutical Group Ltd. trades under the ticker 3320 on HKEX.

Where is China Resources Pharmaceutical Group listed?

China Resources Pharmaceutical Group Ltd. is listed on HKEX. Our directory also records these other listings: GETTEX:640.

Which country or territory is China Resources Pharmaceutical Group listed under?

Our directory records China Resources Pharmaceutical Group Ltd. under Hong Kong.

What does China Resources Pharmaceutical Group do?

Our directory classifies China Resources Pharmaceutical Group Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of China Resources Pharmaceutical Group?

The ISIN recorded for China Resources Pharmaceutical Group Ltd. is HK0000311099.

Does aibio.space cover China Resources Pharmaceutical Group?

aibio.space lists China Resources Pharmaceutical Group Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

What is the latest China Resources Pharmaceutical Group (3320) stock news?

Our latest story on China Resources Pharmaceutical Group, dated Oct 23, 2026: "China Resources Pharmaceutical issues RMB800 million third tranche of notes". A wholly owned subsidiary completed the third 2026 tranche of medium term notes, RMB800 million at 1.45% per annum over three years. Source.

Does China Resources Pharmaceutical Group have debt, a term loan or convertible notes?

Our latest debt story, dated Oct 23, 2026: "China Resources Pharmaceutical issues RMB800 million third tranche of notes". A wholly owned subsidiary completed the third 2026 tranche of medium term notes, RMB800 million at 1.45% per annum over three years. Source.

Which companies are similar to China Resources Pharmaceutical Group?

Companies in our directory listed in the same country and business area as China Resources Pharmaceutical Group: Extrawell Pharmaceutical Holdings, Tianda Pharmaceuticals, Beijing Tong Ren Tang Chinese Medicine Co., InSilico Medicine Cayman TopCo, Pak Fah Yeow International, Dawnrays Pharmaceutical Holdings.

How can I follow China Resources Pharmaceutical Group (3320) news?

Press Follow on this page to add China Resources Pharmaceutical Group to your Following list, or subscribe to the aibio.space newsletter. We have published 7 stories naming China Resources Pharmaceutical Group so far, in Debt Financing.

Investor discussion: China Resources Pharmaceutical Group

Members talk about China Resources Pharmaceutical Group (3320). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at China Resources Pharmaceutical Group, newest first. Each line links the filing it comes from.

  1. Mergers

    Transaction under the Listing Rules: DISCLOSEABLE TRANSACTION PROPOSED ACQUISITION OF LIER CHEMICAL. Source

  2. Financings

    Share or debt issue: PROPOSALS FOR GENERAL MANDATES TO BUY BACK SHARES AND TO ISSUE SHARES, RE-ELECTION OF RETIRING DIRECTORS, APPOINTMENT OF AUDITOR AND NOTICE OF ANNUAL GENERAL MEETING. Source

  3. Financings

    Share or debt issue: PROPOSALS FOR GENERAL MANDATES TO BUY BACK SHARES AND TO ISSUE SHARES, RE-ELECTION OF RETIRING DIRECTORS, ELECTION OF INDEPENDENT NON-EXECUTIVE DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING. Source

  4. Mergers

    Transaction under the Listing Rules: DISCLOSEABLE TRANSACTION COMPLETION OF THE PROPOSED ACQUISITION OF TASLY PHARMACEUTICALS. Source

  5. Mergers

    Transaction under the Listing Rules: DISCLOSEABLE TRANSACTION COMPLETION OF THE PROPOSED ACQUISITION OF GREEN CROSS HK. Source

Press releases

Headlines of China Resources Pharmaceutical Group's own announcements, newest first. Each opens the full release on the newswire that carried it.

  1. HKEXnews

    ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF CR SANJIU FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2026

  2. HKEXnews

    ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF KPC FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2026

  3. HKEXnews

    ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF CR JIANGZHONG FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2026

  4. HKEXnews

    ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF DONG-E-E-JIAO FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2026

  5. HKEXnews

    ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF TASLY PHARMACEUTICAL FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2026

  6. HKEXnews

    INSIDE INFORMATION COMPLETION OF THE ISSUE OF THE THIRD TRANCHE OF THE MEDIUM TERM NOTES 2026 IN THE PRC

  7. HKEXnews

    INSIDE INFORMATION COMPLETION OF THE PUBLIC ISSUANCE OF THE SECOND TRANCHE OF 2026 CORPORATE BONDS IN THE PRC

  8. HKEXnews

    INSIDE INFORMATION POTENTIAL ISSUANCE OF SHARES BY CR PHARMACEUTICAL COMMERCIAL

  9. HKEXnews

    DIVIDEND CURRENCY ELECTION FORM FOR THE INTERIM DIVIDEND FOR THE SIX MONTHS ENDED 30 JUNE 2026

  10. HKEXnews

    INSIDE INFORMATION REGISTRATION OF MEDIUM TERM NOTES BY THE NATIONAL ASSOCIATION OF FINANCIAL MARKET INSTITUTIONAL INVESTORS

  11. HKEXnews

    ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF CR PHARMACEUTICAL COMMERCIAL FOR THE SIX MONTHS ENDED 30 JUNE 2026 IN RELATION TO ISSUANCE OF MEDIUM TERM NOTES AND CORPORATE BONDS IN THE PRC

  12. HKEXnews

    ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF CR PHARMACEUTICAL HOLDINGS FOR THE SIX MONTHS ENDED 30 JUNE 2026 IN RELATION TO ISSUANCE OF MEDIUM TERM NOTES AND CORPORATE BONDS IN THE PRC

  13. HKEXnews

    INTERIM DIVIDEND FOR THE SIX MONTHS ENDED 30 JUNE 2026

  14. HKEXnews

    INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2026

  15. HKEXnews

    ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF CR SANJIU FOR THE SIX MONTHS ENDED 30 JUNE 2026

  16. HKEXnews

    ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF KPC FOR THE SIX MONTHS ENDED 30 JUNE 2026

  17. HKEXnews

    ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF CR JIANGZHONG FOR THE SIX MONTHS ENDED 30 JUNE 2026

  18. HKEXnews

    ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF TASLY PHARMACEUTICAL FOR THE SIX MONTHS ENDED 30 JUNE 2026

  19. HKEXnews

    ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF CR DOUBLE-CRANE FOR THE SIX MONTHS ENDED 30 JUNE 2026

  20. HKEXnews

    ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF CR BOYA BIO-PHARMACEUTICAL FOR THE SIX MONTHS ENDED 30 JUNE 2026

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open HKEX:3320 on TradingView.

Listing details

China Resources Pharmaceutical Group Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 3320, recorded under Hong Kong. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
China Resources Pharmaceutical Group Ltd.
Ticker
3320
Listing
HKEX
Country or territory
Hong Kong
Business scope
Pharmaceuticals: Major
ISIN
HK0000311099
Other listed symbols
GETTEX:640
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.